🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Juraj Koska

Phoenix VA Health Care System

ORCID: 0000-0002-6671-6250
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Triglyceride variability and risk of heart failure events in type 2 diabetes: Results from the ACCORD trial

Diabetes Obesity and Metabolism(2025)10.1111/dom.70083
Top 100%
0DataRank
Top 100%0 citations

Jin Zhou, Juraj Koska, Peter D. Reaven, Daniel S. Nuyujukian

Papers

Driven by 8 papers — median percentile 0. Top paper: “Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes”.

Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes

Diabetes Care(2022)10.2337/dc21-2196
N/A
2.5DataRank · unranked
78 citations

Hertzel C. Gerstein, Paul J. Beisswenger, Peter D. Reaven, Juraj Koska

Blood Pressure Variability and Risk of Heart Failure in ACCORD and the VADT

Diabetes Care(2020)10.2337/dc19-2540
N/A
1.7DataRank · unranked
51 citations

Juraj Koska, Gideon Bahn, Peter D. Reaven, Jin Zhou, Daniel S. Nuyujukian

Relationship of apolipoprotein C-III proteoform composition with ankle-brachial index and peripheral artery disease in the Multi-Ethnic Study of Atherosclerosis (MESA)

Atherosclerosis(2024)10.1016/j.atherosclerosis.2024.117584
N/A
0.241DataRank · unranked
4 citations

Spencer Hansen, Yueming Hu, Majken C Jensen, Dean Billheimer, Dobrin Nedelkov +5 more

Relationship of Plasma Apolipoprotein C-I Truncation With Risk of Diabetes in the Multi-Ethnic Study of Atherosclerosis and the Actos Now for the Prevention of Diabetes Study

Diabetes Care(2024)10.2337/dc24-1462
N/A
0.208DataRank · unranked
3 citations

Yueming Hu, Jeremy D. Furtado, Dean Billheimer, Dobrin Nedelkov, Dawn C. Schwenke +5 more

Triglyceride variability and risk of heart failure events in type 2 diabetes: Results from the ACCORD trial

Diabetes Obesity and Metabolism(2025)10.1111/dom.70083
Top 100%
0DataRank
Top 100%0 citations

Jin Zhou, Juraj Koska, Peter D. Reaven, Daniel S. Nuyujukian

Association of low fasting C-peptide levels with cardiovascular risk, visit-to-visit glucose variation and severe hypoglycemia in the Veterans Affairs Diabetes Trial (VADT)

Cardiovascular Diabetology(2021)10.1186/s12933-021-01418-z
N/A
0DataRank · unranked
22 citations

Daniel S. Nuyujukian, Gideon Bahn, Jin Zhou, Peter D. Reaven, Juraj Koska

Association of Low Fasting C-Peptide Levels With Cardiovascular Risk, Visit-To-Visit Glucose Variation and Severe Hypoglycemia in The Veterans Affairs Diabetes Trial (VADT)

Research Square(2021)10.21203/rs.3.rs-958889/v1
N/A
0DataRank · unranked
0 citations

Daniel S. Nuyujukian, Gideon Bahn, Jin Zhou, Peter D. Reaven, Juraj Koska

Response to Comment on Koska et al. Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes. Diabetes Care 2022;44:684–691

Diabetes Care(2022)10.2337/dci22-0013
N/A
0DataRank · unranked
1 citations

Hertzel C. Gerstein, Paul J. Beisswenger, Peter D. Reaven, Juraj Koska